Danny Andrea is the Director of Product and Projects at Curaleaf International, where she leads the strategy and development of innovative cannabis-based therapeutics across a rapidly growing number of medical markets. Danny oversees the team responsible for the product lifecycle from concept through to market, ensuring pharmaceutical standards and patient-centric outcomes. Most recently, she played a central role in securing approval for the world’s first medically certified liquid cannabis inhalation device — a breakthrough in precision dosing and delivery.